Clinical Trials Browser

Phase 2 × Hemangiosarcoma × spartalizumab × Clear all

NCT05961761 2023-07-27

PROPANE

Phase 2 Recruiting

Hemangiosarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT04607200 2022-01-11

AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma

Phase 2 Withdrawn

Hemangiosarcoma